ACM
MYGN icon

Aquatic Capital Management’s Myriad Genetics MYGN Stock Holding History

Aquatic Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
+22,427
New +$102K ﹤0.01% 1064
2026
Q1 		– Sell
-82,579
Closed -$508K – 1666
2025
Q4 		$508K Buy
82,579
+31,699
+62% +$230K 0.01% 728
2025
Q3 		$368K Buy
50,880
+27,593
+118% +$164K 0.01% 950
2025
Q2 		$124K Sell
23,287
-9,464
-29% -$55.9K ﹤0.01% 1069
2025
Q1 		$291K Buy
32,751
+7,823
+31% +$94K 0.01% 867
2024
Q4 		$342K Buy
24,928
+13,328
+115% +$246K 0.01% 815
2024
Q3 		$318K Buy
11,600
+1,900
+20% +$51.4K 0.01% 735
2024
Q2 		$237K Buy
9,700
+4,800
+98% +$105K 0.01% 715
2024
Q1 		$104K Buy
+4,900
New +$105K ﹤0.01% 902
2023
Q4 		– Sell
-5,200
Closed -$83K – 1526
2023
Q3 		$83K Buy
+5,200
New +$99K ﹤0.01% 853
2023
Q2 		– Sell
-16,100
Closed -$374K – 1610
2023
Q1 		$374K Sell
16,100
-7,800
-33% -$158K 0.02% 469
2022
Q4 		$346K Buy
23,900
+16,700
+232% +$311K 0.03% 596
2022
Q3 		$137K Buy
+7,200
New +$165K 0.01% 687

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aquatic Capital Management's MYGN Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Myriad Genetics (MYGN) in Q2 2026: 22,427 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #1064 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in MYGN as recently as Q4 2025.

Aquatic Capital Management first reported a position in MYGN in Q3 2022 and has held it in 13 quarters since. The position peaked at $508K in Q4 2025. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Aquatic Capital Management held 22,427 shares of Myriad Genetics worth $128K as of Q2 2026.
  • Myriad Genetics was a new Aquatic Capital Management position in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1064 holding.
  • Aquatic Capital Management first reported a position in Myriad Genetics in Q3 2022 and has held it in 13 quarters since.
  • Aquatic Capital Management's Myriad Genetics position peaked at $508K in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.